{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:12:11Z","timestamp":1789906331174,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T00:00:00Z","timestamp":1467676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T00:00:00Z","timestamp":1467676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PO1 CA055075"],"award-info":[{"award-number":["PO1 CA055075"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA141298"],"award-info":[{"award-number":["CA141298"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA13389"],"award-info":[{"award-number":["CA13389"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 CA167552"],"award-info":[{"award-number":["UM1 CA167552"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the US Army Prostate Cancer Research Program Idea Development Award","award":["PC060389"],"award-info":[{"award-number":["PC060389"]}]},{"name":"the DF\/HCC Prostate SPORE Career Development Award","award":["P50 CA90381"],"award-info":[{"award-number":["P50 CA90381"]}]},{"name":"Ohio State University NIH","award":["P30 CA16058"],"award-info":[{"award-number":["P30 CA16058"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s10552-016-0782-x","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T12:01:52Z","timestamp":1467720112000},"page":"1043-1047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade"],"prefix":"10.1007","volume":"27","author":[{"given":"Meng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorelei A.","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Clinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Loda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir J.","family":"Stampfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Giovannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,5]]},"reference":[{"key":"782_CR1","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1200\/JCO.2008.20.4669","volume":"27","author":"JR Stark","year":"2009","unstructured":"Stark JR, Perner S, Stampfer MJ et al (2009) Gleason score and lethal prostate cancer: does 3\u00a0+\u00a04\u00a0=\u00a04\u00a0+\u00a03? J Clin Oncol 27:3459\u20133464","journal-title":"J Clin Oncol"},{"key":"782_CR2","first-page":"439","volume":"8","author":"WA Sakr","year":"1994","unstructured":"Sakr WA, Grignon DJ, Crissman JD et al (1994) High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20\u201369: an autopsy study of 249 cases. In Vivo 8:439\u2013443","journal-title":"In Vivo"},{"key":"782_CR3","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/S0022-5347(05)00734-2","volume":"175","author":"O Andren","year":"2006","unstructured":"Andren O, Fall K, Franzen L, Andersson SO, Johansson JE, Rubin MA (2006) How well does the Gleason score predict prostate cancer death? a 20-year followup of a population based cohort in Sweden. J Urol 175:1337\u20131340","journal-title":"J Urol"},{"key":"782_CR4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s10552-011-9776-x","volume":"22","author":"E Giovannucci","year":"2011","unstructured":"Giovannucci E (2011) Commentary: serum lycopene and prostate cancer progression: a re-consideration of findings from the prostate cancer prevention trial. Cancer Cause Control 22:1055\u20131059","journal-title":"Cancer Cause Control"},{"key":"782_CR5","doi-asserted-by":"publisher","first-page":"e509","DOI":"10.1016\/S1470-2045(12)70388-1","volume":"13","author":"HU Ahmed","year":"2012","unstructured":"Ahmed HU, Arya M, Freeman A, Emberton M (2012) Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol 13:e509\u2013e517","journal-title":"Lancet Oncol"},{"key":"782_CR6","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1200\/JCO.2008.20.8876","volume":"27","author":"LA Mucci","year":"2009","unstructured":"Mucci LA, Powolny A, Giovannucci E et al (2009) Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. J Clin Oncol 27:5627\u20135633","journal-title":"J Clin Oncol"},{"key":"782_CR7","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1158\/1055-9965.EPI-12-0042","volume":"21","author":"A Pettersson","year":"2012","unstructured":"Pettersson A, Graff RE, Bauer SR et al (2012) The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis. Cancer Epidemiol Biomark Prev 21:1497\u20131509","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"782_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3945\/ajcn.115.118703","volume":"103","author":"RE Graff","year":"2016","unstructured":"Graff RE, Pettersson A, Lis RT et al (2016) Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression. Am J Clin Nutr 103:851\u2013860","journal-title":"Am J Clin Nutr"},{"key":"782_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1054\/bjoc.2001.1971","volume":"85","author":"AF West","year":"2001","unstructured":"West AF, O\u2019Donnell M, Charlton RG, Neal DE, Leung HY (2001) Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer. Br J Cancer 85:576\u2013583","journal-title":"Br J Cancer"},{"key":"782_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353\u2013364","journal-title":"Cell"},{"key":"782_CR11","doi-asserted-by":"publisher","first-page":"E794","DOI":"10.1111\/j.1464-410X.2012.11444.x","volume":"110","author":"G Russo","year":"2012","unstructured":"Russo G, Mischi M, Scheepens W, De la Rosette JJ, Wijkstra H (2012) Angiogenesis in prostate cancer: onset, progression and imaging. BJU Int 110:E794\u2013E808","journal-title":"BJU Int"},{"key":"782_CR12","doi-asserted-by":"publisher","first-page":"djt430","DOI":"10.1093\/jnci\/djt430","volume":"106","author":"K Zu","year":"2014","unstructured":"Zu K, Mucci L, Rosner BA et al (2014) Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 106:djt430","journal-title":"J Natl Cancer Inst."},{"key":"782_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/med.20161","volume":"30","author":"Y Li","year":"2010","unstructured":"Li Y, Cozzi PJ (2010) Angiogenesis as a strategic target for prostate cancer therapy. Med Res Rev 30:23\u201366","journal-title":"Med Res Rev"},{"key":"782_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1124\/jpet.114.216382","volume":"350","author":"A Alhusban","year":"2014","unstructured":"Alhusban A, Al-Azayzih A, Goc A, Gao F, Fagan SC, Somanath PR (2014) Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesis. J Pharmacol Exp Ther 350:635\u2013645","journal-title":"J Pharmacol Exp Ther"},{"key":"782_CR15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10456-014-9437-2","volume":"17","author":"CI Lin","year":"2014","unstructured":"Lin CI, Merley A, Sciuto TE et al (2014) TM4SF1: a new vascular therapeutic target in cancer. Angiogenesis 17:897\u2013907","journal-title":"Angiogenesis"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-016-0782-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-016-0782-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-016-0782-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-016-0782-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T12:21:57Z","timestamp":1600863717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-016-0782-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,5]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1007\/s10552-016-0782-x","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,5]]},"assertion":[{"value":"15 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}